Grape Pie (Teen)
Grape Pie (Teen)
One “Grape Pie” teen well established in a 3.5” pot!
These meticulously nurtured plants boast well established roots and a verdant height of approximately 12”, aged between one week and one month from transplanting to shipping!
Grape Pie, born from the union of Grape Stomper and Cherry Pie, emerges as a 70% indica-dominant strain with a THC content ranging from 17-22%. This enticing cultivar takes around 9 weeks to flower, with an ideal outdoor harvest window in early to mid-October.
The Grape Pie strain thrives in Mediterranean climates, favoring stable conditions, making it well-suited for environments with mild seasons or greenhouses. Indoor cultivation is a reliable option for consistent results. For those desiring more pronounced purple hues in the buds, slightly cooler evening temperatures are encouraged, but caution is advised to avoid exposing plants to temperatures below 45 degrees Fahrenheit.
Due to its indica lineage, Grape Pie tends to develop a bushier structure, making it conducive to low-stress training methods. Techniques like Screen of Green (SCROG) or branch tying help create an even canopy, maximizing light exposure to each bud site, resulting in denser and larger harvests.
Monitoring humidity levels is crucial for optimal growth, with a preference for lower humidity levels to ensure a stellar harvest. The buds of Grape Pie present a visually appealing sight—frosty, forest green nugs adorned with a thick, sticky layer of resin trichomes, complemented by vibrant orange pistils and amber trichomes.
The aroma and flavor profile of Grape Pie are a delightful medley of pine, grape, sweetness, sourness, sugary notes, and fruity undertones. This sensory experience is enriched by the strain's terpene profile, featuring myrcene, caryophyllene, and limonene.
Users of Grape Pie have reported that it may offer relief from conditions such as anxiety, chronic pain, depression, insomnia, and mood swings. As a creation of Cannarado Genetics, Grape Pie stands as a testament to their commitment to producing strains with unique characteristics and therapeutic potential.